RxDoctor Payments Data

David Peeler, MD

Diagnostic Radiology · Memphis, TNNPI 1467567867

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $41,290 of the $67,618 with a category attached, or 61.1%. Bard Peripheral Vascular, Inc. accounts for 87.2% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $26,710 and has fallen 97.4% since, to $707 in 2025. Among diagnostic radiology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$67,618in general payments, 2019–2025

Across 331 payments — averaging $204.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$59K
  • C. R. Bard, Inc. & Subsidiaries$4K
  • Cardiovascular Systems Inc.$1K
  • Philips North America LLC$723
  • Penumbra, Inc.$666
  • Abbott$598
  • plus $2K from 15 others

What the payments were for

  • Consulting fees$16,50024%
  • Speaking & faculty fees$41,29061%
  • Food & beverage$9,82815%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$67,618 in reported general payments places this provider in the 95th percentile of 757 diagnostic radiology providers in Tennessee.

See all diagnostic radiology providers in Tennessee

Medicare billing

Part B allowed, 2024
$162,107
Medicare patients
285
Services billed
1,380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate25$347

Paid to pharmacies, not to this prescriber.

Other diagnostic radiology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →